Does the HIPAA Privacy Rule's public health provision permit covered entities to disclose protected health information without authorization to a manufacturer of a product regulated by the Food and Drug Administration (FDA) for use by the manufacturer to assess the effectiveness of its marketing campaign?
Must a health care provider or other covered entity obtain permission from a patient prior to notifying public health authorities of the occurrence of a reportable disease?
Does the HIPAA Privacy Rule's public health provision permit covered health care providers to disclose protected health information concerning the findings of pre-employment physicals, drug tests, or fitness-for-duty examinations to an individuals employer?
Does the HIPAA Privacy Rule's public health provision permit covered entities to disclose protected health information to authorities such as the National Institutes of Health (NIH)?
Is a covered entity permitted to disclose protected health information under the HIPAA Privacy Rule's public health provision when the link between an averse event and a product regulated by the Food and Drug Administration (FDA) is only suspected?
To whom may covered entities make public health disclosures regarding a product regulated by the Food and Drug Administration (FDA) when more than one person is identified on the product label?
Does the HIPAA Privacy Rule permit covered entities to disclose protected health information, without individuals' authorization, to public officials responding to a bioterrorism threat or other public health emergency?
Does the public health provision of the HIPAA Privacy Rule require covered entities to make public health disclosures?